PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6

  1. 6,008 Posts.
    lightbulb Created with Sketch. 1153
    most R & D (trials etc) money probably spent outside of Australia i guess..
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.